Abstract. Long-term effects of Shockwave lithotripsy (SWL) are unknown; however, we recently found an association between SWL and diabetes mellitus in a population based case control cohort. To further study the association between SWL and diabetes mellitus, we determined the immediate impact of SWL on the pancreas as well as the long-term natural history of stone disease following treatment. Chart review identified 630 patients treated with SWL at our institution in 1985. Questionnaires focusing on recurrent stone episodes after SWL were sent to 578 patients alive in 2004. To further assess impact of SWL on the pancreas, pancreatic enzyme measurements were performed on 24 symptomatic stone patients treated in 2006 with ureteroscopy (n=12) and SWL (n=12). Serum amylase and lipase were evaluated pre and post SWL. A >5 U/L increase in either lab value was considered significant. Among patients in the long-term SWL treatment group, the questionnaire response rate was 58.9% (288/489). Recurrent stone events were noted in 154 (53.5%) of the survey respondents. Characteristics associated with stone recurrences were: gender (p=0.004), age at SWL (p=0.022), BMI (p=0.007), SWL complications (p=0.009), and lower pole SWL (p=0.025). Recurrent stone disease was also associated with the development of diabetes mellitus (p=0.020). In the contemporary group of treated stone patients, pancreatic enzyme analysis demonstrated an increase in serum amylase and lipase in 3 (25.0%) SWL patients and 1 (8.3%) ureteroscopy patient (p=0.273). In conclusion, over half of the patients treated with SWL will develop recurrent stone events. We found a strong association between recurrent stone disease and the development of diabetes mellitus at long-term follow-up. Although not statistically significant due to small number, data in a contemporary treatment cohort suggest the possibility that the pancreas can be adversely affected by SWL.
INTRODUCTION
The introduction of shock wave lithotripsy (SWL) by Chaussy and colleagues revolutionized the treatment of stone disease, ushering in the era of minimally invasive management of urinary calculi [1, 2] . Today SWL is the preferred treatment by many urologists for symptomatic urinary calculi such that 80-90% of calculi are currently considered to be amenable to SWL [3] . Although this treatment method is considered safe overall, many early deleterious effects to the kidney and surrounding organs have been identified [3] [4] [5] [6] . Recently, a study from our institution evaluated the long-term effects of SWL after 19 years of follow-up [7] . In this study, patients were asked to report on new conditions related to organs thought to be in the SWL blast path that developed since their original SWL (Fig. 1 ). Survey response rate was 59%. Responders were matched 1:1 with regards to age, gender, and year of presentation to a group of urolithiasis patients treated conservatively (i.e. no surgical intervention). We found an increased risk (Odds Ratio, OR=1.47) of developing hypertension at long-term follow-up after SWL compared to the control group. We also found that patients treated with SWL were more likely to develop diabetes mellitus than controls (OR=3.23). This risk persisted in multivariate analysis controlling for presence of obesity on follow-up and change in BMI (OR's of 3.28 and 3.75, respectively). In addition, the development of diabetes mellitus in the SWL group was associated with the number of shocks administered and the total intensity of the treatment (p=0.005 and />=0.007, respectively). It is known that the incidence of diabetes mellitus is increased in patients with urolithiasis regardless of age, BMI, or diet [8] , but an association between a specific stone treatment and such adverse effects has not previously been published. Although prior studies have demonstrated acute pancreatitis, changes in pancreatic enzymes [4, [9] [10] [11] , and pancreatic hematomas after SWL [12] , skepticism still exists as to whether the pancreas is damaged enough to produce structural changes resulting in functional deficits.
Multiple theories may explain the observed association between SWL and diabetes. Shear and cavitational forces, for example, are known to cause soft tissue injury after SWL [11, 13] . These forces may alter the islet cell cycle as they pass through the pancreas, leading to an increased rate of cellular apoptosis and eventual diabetes mellitus. Neural tissue studies have demonstrated increased rates of cellular apoptosis when nerve cells are exposed to intense noise shock waves. This effect is accentuated by coexisting surgical lesions [14] . Another theory is that damage to the pancreas results in pancreatic antigen release and eventual pancreatic autoimmune destruction. Pancreatic antigen exposure to the immune system is known to cause diabetes mellitus in certain individuals [15] . Or, simply, SWL may damage limited pancreatic reserves in patients already at increased risk of developing diabetes mellitus.
Other long-term treatment concerns with SWL may be contributing to this association. Since this treatment method relies on passage of stone fragments, the rate of stone recurrence for SWL if fragments persist may be higher than other treatment modalities. Multiple stone recurrences could result in further surgical interventions and increased rates of long-term adverse events. The goal of our current work was to determine the long-term natural history of stone disease after SWL as well as the immediate impact of SWL on pancreatic function in a contemporary SWL treatment cohort.
METHODS

Stone Recurrences after Shock Wave Lithotripsy
After approval from the Mayo Clinic Institutional Review Board a retrospective review identified 630 consecutive patients with renal and ureteral calculi who underwent SWL using an HM-3 lithotripter in 1985. This year marked the first year of SWL at our institution. Preoperative patient demographics, preexisting medical conditions, stone demographics, and treatment characteristics were collected. Preexisting renal insufficiency was defined as serum creatinine greater than 1.4 mg/dL in males and greater than 1.2 mg/dL in females. Preexisting obesity was defined as BMI of 30 or greater. Preexisting hypertension was defined as a diagnosis of hypertension requiring antihypertensive medications. Stone analysis was performed on gravel passed via the urethra after treatment to determine composition. Hematuria with clot retention was considered a postoperative complication.
Survey of Cases
A structured questionnaire was sent to 578 SWL patients listed in our clinic records as being alive in 2004. The questionnaire, which was developed and distributed with the Mayo Clinic Survey Research Center, focused on the development of subsequent stone recurrences after the initial SWL treatment in 1985. The survey inquired about the number of recurrences, date of recurrences, location (right versus left), and method of treatment.
Pancreatic Enzyme Measurements
After approval from the Mayo Clinic Institutional Review Board 24 patients with symptomatic renal or ureteral calculi were enrolled in this prospective study. Stone burden was treated ureteroscopically in 12 patients or with SWL in the remaining 12 patients. Ureteroscopic treatment consisted of laser lithotripsy or basket extraction. The electrohydraulic HM-3 lithotripter was used for SWL. Serum amylase and lipase were evaluated the day prior to the surgical procedure and 2 hours post procedure, prior to dismissal from the outpatient surgical setting. A >5 U/L increase in either lab value from preoperative to postoperative was considered a clinical meaningful change. Normal reference ranges at our laboratory for serum amylase and lipase are 26-102 U/L and 10-73 U/L, respectively. All interventions were performed under general anesthesia with paralysis.
Statistical Analysis
Comparisons of age and sex between questionnaire responders and nonresponders were evaluated using the Wilcoxon rank sum and chi-square tests. Associations with SWL features with long-term stone recurrences were evaluated using chi-square and two-sample t tests. Conditional logistic regression models were used to evaluate the risk of long-term stone recurrent events for SWL patients compared with controls. Comparisons of pancreatic enzyme changes between the SWL and ureteroscopy groups were evaluated using a two-sample t-test. Statistical analyses were performed using the SAS software package (SAS Institute, Cary, North Carolina) with p<0.05 considered statistically significant.
RESULTS
Stone Recurrence after Shock Wave Lithotripsy
Retrospective Review of All Patients Treated with SWL
Retrospective chart review revealed a total of 687 SWL treatments in 630 patients from January 1, 1985 to December 31, 1985. Eight patients were excluded: 7 due to age and 1 who declined to participate in medical research. Median patient age was 52 years (range 18 to 90). There were 218 females and 404 males. Stone location was left sided in 384 cases, right sided in 295 and bilateral in 57. There were 541 solitary renal stones, 27 multiple renal stones and 114 proximal ureteral stones. According to available stone sizes, 34.9% of the stones were less than 1 cm, 58.4% were 1 cm or greater and 6.6% were partial staghorn calculi. Greater than 50% of the stones were composed of the following: calcium oxalate monohydrate in 292 (43%), calcium oxalate dihydrate in 115 (16.9%), calcium phosphate in 123 (18.1%), uric acid in 28 (4.1%), magnesium ammonium phosphate in 17 (2.5%), cystine in 4 (0.6%), and unknown for 72 (24.8%).
Comparison of Questionnaire Responders and Nonresponders
Of the 578 questionnaires mailed, 89 were returned uncompleted because the patient was deceased. The completed survey response rate was 58.9%. There were no significant differences in age and sex between the 288 responders and 201 nonresponders. Of the questionnaire responders 228 (81.4%) had been referred for SWL and did not return to our institution for postoperative follow-up. Table 1 lists demographics, comorbidities, stone location, and treatment characteristics for the survey respondents. Median patient weight at treatment was 79.0 kg (range 42.0 to 134.5). Stone location in this group was renal in 236 (81.9%) and proximal ureteral in 52 (18.1%). Overall 3 patients received greater than 2,000 shocks in a single setting and 10 received greater than 2,000 shocks as a cumulative amount during multiple SWL's. Of the survey respondents 222 (78.5%) were referred to a nephrology stone clinic in 1985 for metabolic evaluation and treatment. An immediate postoperative complication was noted in 40 of the 288 responders (13.9%), as summarized in Table 2 . No clinically significant perinephric hematomas were noted. Of the 288 survey respondents, recurrent stone events after original SWL were noted in 154 (53.5%), as summarized in Table 3 . Analysis of patient demographics, stone characteristics, and treatment characteristics with stone recurrences was performed (Table 4) . Certain patient and treatment characteristics were associated with recurrent stone disease including: gender (^=0.004), age at original SWL (p=Q.Q22), BMI (/?=0.007), any complication at original SWL (/?=0.009), and SWL of a lower pole stone (p=Q.Q25). Referral to nephrologist in the year 1985 did not predict stone recurrence (p=Q.\61). Recurrent stone disease was not associated with the subsequent development of new onset hypertension (/?=0.088) or renal insufficiency (p=Q.\61).
Questionnaire Respondents
Stone recurrence was significantly associated with the subsequent development of new onset diabetes mellitus (p=0.020). 
Pancreatic Enzyme Measurements
There was no statistically significant difference between the ureteroscopy and SWL groups with regards to patient demographics (Table 5 ) or stone size. Mean SWL voltage was 20 kV (18) (19) (20) (21) (22) and all SWL patients received 2000 shocks. An increase in serum amylase was noted in 3 (25.0%) SWL patients and 1 (8.3%) ureteroscopy patient (p=0.273). An increase in serum lipase was also noted in 3 (25.0%) SWL patients and 1 (8.3%) ureteroscopy patient (p=0.273). All pancreatic enzyme elevations were within the normal laboratory value limits. Only those patients with left sided SWL's demonstrated increases in serum amylase and lipase.
DISCUSSION
Recently a link between diabetes mellitus and patients with urolithiasis has been identified, with urolithiasis patients having a higher rate of diabetes mellitus compared to non-stone formers [8] . Further evidence has demonstrated a link between specific treatments for urolithiasis and the development of adverse medical conditions [7] . Since its introduction, strong evidence has implicated SWL as a cause of transient acute damage to the kidney and surrounding tissues [16] . However, it was not until recently that long-term studies associated SWL with the development of adverse medical conditions such as diabetes melhtus and hypertension [7] . The current study further evaluates this association by analyzing long-term stone recurrence rates after SWL and by evaluating the acute effects of SWL on the pancreas. With long-term follow-up approximately 54% of patients will experience a recurrent stone event and many will experience multiple stone events after SWL. These results are similar to the accepted 10-year recurrence rates for calcium oxalate stones treated conservatively 50% [17] . Other intermediate studies (<5 years) following children treated with SWL have demonstrated significant stone recurrences rates, but none as high as 50% [18, 19] . We also noted certain preoperative and operative characteristics were associated with stone recurrence such as: age at SWL, obesity, gender, any complication at original SWL, and SWL of lower pole calculi. We did not find an association with preexisting diabetes mellitus, hypertension, or renal insufficiency and recurrent stone disease. However, those patients who developed multiple stone recurrences after their original SWL were more likely to develop new onset diabetes mellitus than those patients who did not experience a recurrence. These findings suggest that recurrent symptomatic stone disease may somehow provoke the development of diabetes mellitus, however the mechanism is unknown. There was no association between recurrent stone disease and the development of new onset hypertension or renal insufficiency. We also found no association between referral to nephrology stone clinic at time of original stone treatment and the development of recurrent stone disease.
Pancreatic enzyme findings in this study provide further evidence that the pancreas is affected by SWL and presents a possible initial mechanistic link between SWL and diabetes mellitus. Although not statistically significant, we did find that more patients in the SWL group (25%) developed subclinical elevations in pancreatic enzymes post procedure compared to the ureteroscopy group (8%). Of note, only those patients with left sided SWL experienced elevation of pancreatic enzymes, which is most likely the result of the anatomic proximity of the pancreas to the left kidney. It also bears mentioning that the one patient in the ureteroscopy group who demonstrated elevations in pancreatic enzymes post procedure was known to have significant peripheral vascular disease and experienced an acute hypotensive episode during the procedure, which may have contributed to the pancreatic enzyme elevations. These findings of pancreatic enzyme elevations after SWL are supported by previous case reports of acute pancreatitis [10-12,16] and those demonstrating pancreatic enzyme elevations after SWL [4, 9] . Kirkali et al demonstrated that serum amylase, lipase and urinary amylase were all elevated after SWL of proximal ureteral and renal stones using an electromagnetic lithotripter up to one week post SWL [9] . Pancreatic enzyme elevations did not occur when low ureteral stones were treated implicating direct damage to the pancreas by shock waves.
We do recognize certain limitations of the long-term follow-up study. Patients who died before 2004 were not studied and therefore adverse long-term outcomes in these patients are not available. The response rate to the survey is altered by the proportion of deceased patients. Only 18.6% of the patients were followed at our institution. Therefore, the 58.9% response rate may be falsely low due to surveys sent to unrecognized deceased patients. Due to the multiple different treatments received for stone recurrences, we are unable to accurately determine if subsequent treatment modalities are specifically associated with the development of adverse medical conditions.
CONCLUSION
Among a group of patients treated with SWL at 19 years follow-up 53.5% developed recurrent stone events. Obesity, age, gender, complicated SWL, and treatment of lower pole stones predisposed patients to recurrent stone events. In addition, recurrent stone disease was noted to be associated with the development of new onset diabetes mellitus at long-term follow-up. In 25.0% of patients treated with HM3 SWL, pancreatic enzymes were elevated, yet the increase was not significant when compared to a ureteroscopy control group in this small trial.
